Working collaboratively to provide creative solutions
to protein challenges in drug discovery
Making sense of Bio-Logics
This month we're focusing on one of our areas of specialisation - Biotherapeutic proteins.
At Peak Proteins (part of Sygnature Discovery) we have extensive experience supporting early-stage development of protein based biotherapeutic molecules.
The Role of Structural Biology in the Development of Biotherapeutics
We discuss the critical role structural biology plays in the design, engineering and application of therapeutic antibodies.
Recent publication on the Development of New Anti-Thrombotic Biotherapeutics
Two Peak Proteins/Sygnature scientists, Juli Warwicker and Mark Abbott, have recently co-authored a paper on a new family of anti-thrombotic therapeutics.
